Skip to content
Subscriber Only

Takeda Hid Diabetes Medicine’s Cancer Risks, Jury Told

Takeda Pharmaceutical Co. executives hid the cancer risks of its diabetes medicine Actos to protect billions of dollars in sales, a lawyer for two women argued.

Takeda officials failed to warn consumers and doctors adequately about the company’s research that linked Actos to bladder cancer, Robert Eglet, a lawyer for Delores Cipriano and Bertha Triana, both of whom developed the disease after taking the drug, told jurors yesterday in closing arguments in a Las Vegas trial.